Ticker Hub
CLDI — AI Analysis & Sentiment
3 recent AI-generated analyses for CLDI. Sentiment and confidence insights updated continuously.
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing
Calidi Biotherapeutics has received supportive FDA feedback for its CLD-401 manufacturing process, removing a significant hurdle for clinical devel...
Mar 12, 2026Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
Calidi Biotherapeutics' $5.2 million public offering represents extreme dilution for a company with a market value of under $3 million, driven by h...
Mar 6, 2026Calidi Biotherapeutics Announces Proposed Public Offering
Calidi Biotherapeutics' proposed public offering signals financial strain and potential dilution, creating a short-term bearish opportunity.
Mar 5, 2026